Lyphochek 664
Lyphochek 664 is a benzodiazepine group IVD (FDA Class I; FDA product code DIF, Drug Mixture Control Materials) made by Bio-Rad Laboratories, cleared under FDA 510(k) K955153 on 5 Feb 1996 and listed in FDA GUDID since 9 Jan 2017 (UDI-DI 00847661000600), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00847661000600 | Date9 Jan 2017 | StatusListed |
| United States | FDA 510(k)SESE | NumberK955153 | Date5 Feb 1996 | StatusActive |
Official records
- AccessGUDID record 00847661000600
- FDA 510(k) database K955153
From the FDA record
- Device description
- Lyphochek Benzo/TCA Control- Set B Level 2 (A human serum assayed benzodiazepines and TCA control.)
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K955153 decided 5 Feb 1996 Active
- FDA GUDID UDI-DI 00847661000600 listed 9 Jan 2017 Listed
Timeline
- Cleared FDA 510(k) K955153
- Listed FDA GUDID 00847661000600
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Lyphochek
- Generic name
- Benzodiazepine group IVD, control
- Model / Ref / Catalog
- 664
- Primary DI / UDI-DI
- 00847661000600
- 510(k) Number
- FDA product code
- DIF
- GMDN term
- Benzodiazepine group IVD, control
- Device class
- Class I
- Regulation number
- 862.3280
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code DIF (DRUG MIXTURE CONTROL MATERIALS).
- EMIT 700 CONTROL SET A by Syva Co.
- ANTI-ARRHYTHMIC CONTROL LEVELS I & II by Environmental Chemical Specialties
- TRIAGE TOX DRUG SCREEN CONTROLS by Biosite Incorporated
- LYPHOCHEK URINE TOXICOLOGY CONTROL - NEGATIVE by Bio-Rad
- TRI-LEVEL TDM CONTROL & I II III by Ortho Diagnostic Systems, Inc.
- FLURAZEPAM TOXICOLOGY CONTROL by UTAK Laboratories Inc.
- ONTRAK TESTTCUP COLLECTION/URINALYSIS PANEL by Roche Diagnostic Systems, Inc.
- DETECTABUSE LIQUID CONTROL, DETECTABUSE STAT-SKREEN LIQUID CONTROL by BIOCHEMICAL DIAGNOSTICS INC
- ACS THERAPEUTIC DRUG MONIT CONTR, SET I, LEVEL III by Analytical Control Systems
- CARDIACS I TOXICOLOGY CONTROL by UTAK Laboratories Inc.